Fertility and Sterility
Volume 91, Issue 4 , Pages 979-987 , April 2009

High expression levels of cyclin B1 and Polo-like kinase 1 in ectopic endometrial cells associated with abnormal cell cycle regulation of endometriosis

  • Li Tang, Ph.D.

      Affiliations

    • Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China
    • Department of Reproductive Endocrinology, The First People's Hospital of Yunnan Province, Kunming, Yunnan, People's Republic of China
    • ,
  • Ting-Ting Wang, M.D.

      Affiliations

    • Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China
    • ,
  • Yan-Ting Wu, M.D.

      Affiliations

    • Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China
    • ,
  • Cai-Yun Zhou, B.S.

      Affiliations

    • Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China
    • ,
  • He-Feng Huang, M.D.

      Affiliations

    • Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China
    • Corresponding Author InformationReprint requests: He-Feng Huang, M.D., Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, 2 Xue Shi Road, Hangzhou, Zhejiang, 310006, People's Republic of China (FAX: 86-571-88208022).

Received 29 July 2007 ,Revised 8 January 2008 ,Accepted 11 January 2008.

References 

  1. Missmer AS, Hankinson SE, Spiegelman D, Barbieri RL, Malspeis S, Willett WC. Reproductive history and endometriosis among premenopausal women. Obstet Gynecol. 2004;104:965–974
  2. Somigliana E, Vigano P, Parazzini F, Stoppelli S, Giambattista E, Vercellini P. Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence. Gynecol Oncol. 2006;10:1–11
  3. Bruner-Tran KL, Zhang Z, Eisenberg E, Winneker RC, Osteen KG. Down-regulation of endometrial matrix metalloproteinase-3 and -7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, tanaproget. J Clin Endocrinol Metab. 2006;91:1554–1560
  4. Di Blasio AM, Di Francesco S, Abbiati A, Vigano P. Genetics of endometriosis. Minerva Ginecol. 2005;57:225–236
  5. Radomski D, Marcyniak M, Milewczyk P, Zdanowska K, Roszkowski PI. Immunologic and genetic aspects of endometriosis physiopathology. Ginekol Pol. 2002;73:68–73
  6. Bedaiwy MA, Falcone T. Peritoneal fluid environment in endometriosis. Clinicopathological implications. Minerva Ginecol. 2003;55:333–345
  7. Fukunaga M, Nomura K, Ishikawa E, Ushigome S. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology. 1997;30:249–255
  8. Swiersz LM. Role of endometriosis in cancer and tumor development. Ann N Y Acad Sci. 2002;955:281–292discussion 293–5, 396–406
  9. Del Carmen MG, Smith Sehhdev AE, Fader AN, Zahurak ML, Richardson M, Fruehauf JP, et al. Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors. Cancer. 2003;98:1658–1663
  10. Amemiya S, Sekizawa A, Otsuka J, Tachikawa T, Saito H, Okai T. Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability. Int J Gynaecol Obstet. 2004;86:371–376
  11. Varma R, Rollason T, Gupta JK, Maher ER. Endometriosis and the neoplastic process. Reproduction. 2004;127:293–304
  12. Pan H, sheng JZ, Tang L, Zhu R, Zhou TH, Huang HF. Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients. Fertil Steril doi:10.1016/j.fertnstert.2007.07.1386.
  13. Sampson J. Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ. Arch Surg. 1925;10:1–72
  14. Benoit L, Arnould L, Cheynel N, Diane B, Causeret S, Machado A, et al. Malignant extraovarian endometriosis: a review. Eur J Surg Oncol. 2006;32:6–11
  15. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol. 1997;176:572–579
  16. Melin A, Sparen P, Persson I, Bergqvist A. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod. 2006;21:1237–1242
  17. Kondi-Pafiti A, Spanidou- Cravouni H, Papadias K, Hatzistamou-Kiari I, Kontogianni K, Liapis A, et al. Malignant neoplasms arising in endometriosis: clinicopathological study of 14 cases. Clin Exp Obstet Gynecol. 2004;31:302–304
  18. Wingfield M, Macpherson A, Healy DL, Rogers PA. Cell proliferation is increased in the endometrium of women with endometriosis. Fertil Steril. 1995;64:340–346
  19. Jackman M, Lindon C, Nigg EA, Pines J. Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat Cell Biol. 2003;5:143–148
  20. Jin P, Hardy S, Morgan DO. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J Cell Biol. 1998;141:875–885
  21. Glover DM, Hagan IM, Tavares AA. Polo-like kinases: a team that plays throughout mitosis. Genes & Dev. 1998;12:3777–3787
  22. Charrasse S, Lorca T, Doree M, Larroque C. The Xenopus XMAP215 and its human homologue TOG proteins interact with cyclin B1 to target p34cdc2 to microtubules during mitosis. Exp Cell Res. 2000;254:249–256
  23. Ito Y, Nakamura Y, Yoshida H, Tomoda C, Uruno T, Takamura Y, et al. Polo-like kinase 1 expression in medullary carcinoma of the thyroid: its relationship with clinicopathological features. Pathobiology. 2005;72:186–190
  24. Rudolph P, Kuhling H, Alm P, Ferno M, Baldetorp B, Olsson H, et al. Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer. Int J Cancer. 2003;105:674–680
  25. Weichert W, Kristiansen G, Winzer KJ, Schmidt M, Gekeler V, Noske A, et al. Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications. Virchows Arch. 2005;446:442–450
  26. Weichert W, Kristiansen G, Schmidt M, Gekeler V, Noske A, Niesporek S, et al. Polo-like kinase 1 expression is a prognostic factor in human colon cancer. World J Gastroenterol. 2005;11:5644–5650
  27. Grabsch H, Lickvers K, Hansen Q, Taken S, Willers R, Stock W, et al. Prognostic value of cyclin B1 protein expression in colorectal cancer. Am J Clin Pathol. 2004;122:511–516
  28. Takeno S, Noguchi T, Kikuchi R, Uchida Y, Yokoyama S, Muller W. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer. 2002;94:2874–2881
  29. Weichert W, Denkert C, Schmidt M, Gekeler V, Wolf G, Kobel M, et al. Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma. Br J Cancer. 2004;90:815–821
  30. Weichert W, Schmidt M, Gekeler V, Denkert C, Stephan C, Jung K, et al. Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades. Prostate. 2004;60:240–245
  31. Farhan L, Dawson M, Rishi AK, Zhang Y, Van Buren E, Trivedi C, et al. Cyclin B and E2F-1 expression in prostate carcinoma cells treated with the novel retinoid CD437 are regulated by the ubiquitin-mediated pathway. Cancer Res. 2002;62:3842–3849
  32. Mitselou A, Toachim E, Zagorianakou N, Kitsiou E, Vougiouklakis T, Agnantis NJ. Expression of the cell-cycle regulatory proteins (cyclins D1 and E) in endometrial carcinomas: correlations with hormone receptor status, proliferating indices, tumor suppressor gene products (p53, pRb), and clinicopathological parameters. Eur J Gynaecol Oncol. 2004;25:719–724
  33. Goumenou AG, Matalliotakis IM, Tzardi M, Fragouli IG, Mahutte NG, Arici A. p16, retinoblastoma (pRb), and cyclin D1 protein expression in human endometriotic and adenomyotic lesions. Fertil Steril. 2006;85:1204–1207
  34. American Society for Reproductive Medicine . Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997;67:817–821
  35. Metzger DA, Olive DL, Haney AF. Limited hormonal responsiveness of ectopic endometrium: histologic correlation with intrauterine endometrium. Hum Pathol. 1988;19:1417–1424
  36. Kitawaki J, Kusuki I, Koshiba H, Tsukamoto K, Fushiki S, Honjo H. Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis. Fertil Steril. 1999;72:1100–1106
  37. Huang HF, Hong LH, Tan Y, Sheng JZ. Matrix metalloproteinase-2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis. Fertil Steril. 2004;81:1235–1239
  38. Kayaselcuk F, Erkanli S, Bolat F, Seydaoglu G, Kuscu E, Demirhan B. Expression of cyclin H in normal and cancerous endometrium, its correlation with other cyclins, and association with clinicopathologic parameters. Int J Gynecol Cancer. 2006;16:402–408
  39. Shiozawa T, Li SF, Nakayama K, Nikaido T, Fujii S. Relationship between the expression of cyclins/cyclin-dependent kinases and sex-steroid receptors/Ki67 in normal human endometrial glands and stroma during the menstrual cycle. Mol Hum Reprod. 1996;2:745–752
  40. Takai N, Miyazaki T, Miyakawa I, Hamanaka R. Polo-like kinase expression in normal human endometrium during the menstrual cycle. Reprod Fertil Dev. 2000;12:59–67
  41. Obermann EC, Went P, Pehrs AC, Tzankov A, Wild PJ, Pileri S, et al. Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma. Oncol Rep. 2005;14:1461–1467
  42. Kanaji S, Saito H, Tsujitani S, Matsumoto S, Tatebe S, Kondo A, et al. Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma. Oncology. 2006;70:126–133
  43. Yuan J, Horlin A, Hock B, Stutte HJ, Rubsamen-Waigmann H, et al. Polo-like kinase, a novel marker for cellular proliferation. Am J Pathol. 1997;150:1165–1172
  44. Yuan J, Eckerdt F, Bereiter-Hahn J, Kurunci-Csacsko E, Kaufmann M, Strebhardt K. Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1. Oncogene. 2002;21:8282–8292
  45. Nalbanski A, Karag'ozov I, Kiurkchiev D, Kiurkchiev S. Cell proliferation in endometrium of women with endometriosis. Akush Ginekol. 2004;43:36–38
  46. Guan R, Tapang P, Leverson JD, Albert D, Giranda VL, Luo Y. Small interfering RNA-mediated Polo-like kinase 1 depletion preferentially reduces the survival of p53-defective, oncogenic transformed cells and inhibits tumor growth in animals. Cancer Res. 2005;65:2698–2704
  47. Yuan J, Yan R, Kramer A, Eckerdt F, Roller M, Kaufmann M, et al. Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene. 2004;23:5843–5852
  48. Liu X, Lei M, Erikson RL. Normal cells, but not cancer cells, survive severe Plk1 depletion. Mol Cell Biol. 2006;26:2093–2108
  49. Norbury C, Nurse P. Animal cell cycles and their control. Annu Rev Biochem. 1992;61:441–470
  50. Pines J, Hunter T. The differential localization of human cyclins A and B is due to a cytoplasmic retention signal in cyclin B. EMBO J. 1994;13:3772–3781
  51. De Souza CP, Ellem KA, Gabrielli BG. Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events. Exp Cell Res. 2000;257:11–21
  52. Hunter T, Pines J. Cyclins and cancer. Cell. 1991;66:1071–1074
  53. Jones RK, Bulmer JN, Searle RF. Immunohistochemical characterization of proliferation, oestrogen receptor and progesterone receptor expression in endometriosis: comparison of eutopic and ectopic endometrium with normal cycling endometrium. Hum Reprod. 1995;10:3272–3279
  54. Oviedo PJ, Hermenegildo C, Tarin JJ, Cano A. Raloxifene increases proliferation of human endothelial cells in association with increased gene expression of cyclins A and B1. Fertil Steril. 2007;88:326–332
  55. Wolf G, Hildenbrand R, Schwar C, Grobholz R, Kaufmann M, Stutte HJ, et al. Polo-like kinase: a novel marker of proliferation: correlation with estrogen-receptor expression in human breast cancer. Pathol Res Pract. 2000;196:753–759
  56. Toyoshima-Morimoto F, Taniguchi E, Shinya N, Iwamatsu A, Nishida E. Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase. Nature. 2001;410:215–220

 L.T. has nothing to disclose. T.-T.W. has nothing to disclose. Y.-T.W. has nothing to disclose. C.-Y.Z. has nothing to disclose. H.-F.H. has nothing to disclose.

 Li Tang and Ting-Ting Wang contributed equally to this study.

 Supported by the National Natural Science Foundation of China (30670789), National Basic Research Program of China (2006CB944006, 2006CB504004), Key Research Program of Zhejiang Province (2006C13078), and Key Research Program of Education of Zhejiang Province (20061382).

PII: S0015-0282(08)00136-2

doi: 10.1016/j.fertnstert.2008.01.041

Fertility and Sterility
Volume 91, Issue 4 , Pages 979-987 , April 2009

Article Tools

* Image Usage & Resolution